12 Cheap Healthcare Stocks to Buy in 2023
The healthcare sector is one of the few industries that has rapidly transformed itself in just a couple of decades.
Bluebird Bio Inc. (BLUE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tang Capital Management Kevin C. Tang | 4,635,528 | $32,077,854 | -27% | 4.66% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,499,715 | $17,298,028 | 0.1% | |
| 3. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,290,699 | $8,931,637 | +14% | 0.11% |
| 4. | Point72 Asset Management Steve Cohen | 1,208,089 | $8,359,976 | 0.02% | |
| 5. | Balyasny Asset Management Dmitry Balyasny | 947,607 | $6,557,440 | +701% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $52.26 | 4,781 | Officer, Director | 17,186 | 2015-12-08 | Filing | |
| $51.25 | 4,901 | Officer, Director | 12,405 | 2015-12-08 | Filing | |
| $85.00 | 1,176 | Director | 1,176 | 2014-12-19 | Filing | |
| $85.00 | 2,352 | Director | 5,293 | 2014-12-19 | Filing | |
| $34.00 | 2,941 | Director | 2,941 | 2014-07-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.46 | 1,004 | 11,466 | 2022-10-17 | Filing | ||
| $7.80 | 3,178 | 242,690 | 2023-01-11 | Filing | ||
| $7.80 | 557 | 74,231 | 2023-01-11 | Filing | ||
| $7.80 | 4,290 | 280,149 | 2023-01-11 | Filing | ||
| $6.41 | 218 | 74,788 | 2022-11-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 12,759,471 | $88,295,539 | 0% | |
| 2. | 7,368,662 | $50,991,140 | 0% | |
| 3. | 4,266,320 | $29,522,935 | 0% | |
| 4. | 1,758,040 | $12,165,637 | 0% | |
| 5. | 1,655,533 | $11,456,288 | 0.01% |
News See All
Top 25 Smartest Companies To Buy According To Hedge Funds
Surviving in the modern day corporate world is not for the faint of heart. Business is a ruthless endeavor, and shareholder and investor interest reign supreme for each company.
15 Most Shorted Stocks Hedge Funds Are Buying
The year 2022 has been a dynamic year for financial markets worldwide.
5 Best High Short Interest Stocks to Buy Now
In this article, we discuss the 5 best high short interest stocks to buy now.
10 Most Promising Gene Therapy Companies to Watch
Gene therapy is a revolutionary new technology that has followed the growing advances in computing power.
10 Best Genomics Stocks to Buy Now
Genomics is the branch of biology that deals with the study of human genes. The genome is the complete set of DNA of an organism. Every cell carries copies of nearly three billion DNA base pairs.
Hedge Funds Aren't Crazy About bluebird bio Inc (BLUE) Anymore
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious...
Hedge Funds Are Souring On bluebird bio Inc (BLUE)
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Is BLUE Stock A Buy or Sell?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Where Do Hedge Funds Stand On bluebird bio Inc (BLUE)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Billionaire Hedge Funds
